Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James McWilliam

Foot and Ankle Surgery Harrison, NY Medical Doctor

NPI 1467567305 CMS profile 293809

600 Mamaroneck Ave, Suite 101, Harrison, NY 10528

Open in the dashboard

General payments

$4,744,930

800 records reported · program years 2019–2025

Research payments

$7,125

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James McWilliam of Harrison, NY is reported in the CMS Open Payments database as having received $4,744,930 across 800 general payments and $7,125 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,087,729 80
2025 Research $7,125 1
2024 General $1,226,460 122
2023 General $714,585 129
2022 General $468,932 50
2021 General $509,257 90
2020 General $314,944 56
2019 General $423,023 273

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James McWilliam
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to James McWilliam were reported at $1,087,729. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year James McWilliam Foot and Ankle Surgery median Middle half National median
2019 $423,023 $1,327 $279–$5,421 $163
2020 $314,944 $795 $121–$3,473 $114
2021 $509,257 $1,289 $201–$4,963 $132
2022 $468,932 $1,539 $270–$6,067 $149
2023 $714,585 $1,117 $257–$5,264 $160
2024 $1,226,460 $1,064 $235–$4,944 $164
2025 $1,087,729 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $4,735,686 691 payments
  2. Gotham Surgical Solutions & Devices, Inc. $4,504 15 payments
  3. Stryker Corporation $1,089 14 payments
  4. Treace Medical Concepts, Inc. $815 12 payments
  5. Integra LifeSciences Corporation $600 12 payments
  6. Bioventus LLC $478 8 payments
  7. Smith+Nephew, Inc. $385 8 payments
  8. Horizon Therapeutics plc $195 11 payments
  9. Flower Orthopedics Coporation $176 2 payments
  10. Forma Medical $142 2 payments
  11. Other $861 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $3,999,863 28 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $442,401 87 payments
  3. Consulting Fee $227,650 131 payments
  4. Travel and Lodging $59,072 220 payments
  5. Food and Beverage $12,174 330 payments
  6. Education $3,769 4 payments
Products named General payments · program years 2019–2025
  1. Arthrex Foot & Ankle and Trauma - Implants - Soft Tissue - Knotless Anchors - FiberTak $1,988,143 8 payments
  2. Arthrex Upper Extremity - Implants - Biceps - FiberTak $1,111,170 4 payments
  3. Arthrex Foot & Ankle and Trauma - Implants - Soft Tissue - Anchors $1,111,170 4 payments
  4. Arthrex Foot & Ankle and Trauma - Implants - Soft Tissue - Anchors - FiberTak $994,072 4 payments
  5. Arthrex Upper Extremity - Implants - Biceps - FiberTak - Knotted $994,072 4 payments
  6. Arthrex Foot & Ankle and Trauma - Implants - Soft Tissue - Knotless Anchors $953,592 3 payments
  7. ARTHREX Distal Extremities - Implants - Soft Tissue - Ib Ligament Augmentation $832,929 8 payments
  8. ARTHREX Distal Extremities - Instruments - Soft Tissue - Disposable Kits $832,929 8 payments
  9. ARTHREX Distal Extremities - Implants - Soft Tissue - Anchors $832,929 8 payments
  10. ARTHREX Shoulder - Implants - Biceps Repair - Fibertak $832,929 8 payments
  11. Other $8,581,644 253 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Arthrex, Inc. $7,125 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

60

Median for Orthopedic Surgery: 203

Drug cost

$1,797

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 42 $1,755
Meloxicam Generic 18 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$128,645

Of which drugs: $113

Medicare patients

418

Average age 73

Services billed

2,179

310 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 62%
Diabetes 26%
Ischemic heart disease 24%
Osteoporosis 24%
Depression 20%
Cancer 18%
Atrial fibrillation 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 16 840 $83

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

801 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record